Last reviewed · How we verify

NCT03577015

International Prospective Registry of Disseminated Intravascular Coagulation

Status unknown Last updated 13 August 2018
What this trial tests

trial in Disseminated Intravascular Coagulation in 1,000 participants. Status unknown.

Timeline
1 November 2017
Primary endpoint
1 April 2021
1 June 2021

Quick facts

Lead sponsorMarcella Muller
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,000
Start date1 November 2017
Primary completion1 April 2021
Estimated completion1 June 2021
Sites1 location across Netherlands

Conditions studied

Sponsor

Marcella Muller

Who can join

18 and older, any sex, with Disseminated Intravascular Coagulation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objectives: to evaluate the current diagnostic and therapeutic approaches for sepis-associated disseminated intravascular coagulation (DIC) in a large prospective registry. Design: prospective, multicenter, international registry. Study population: patients 18 years or older with severe infection to be potentially associated with DIC will be eligible for the study. The clinical visits and monitoring of the patients will follow local routine practices. No specific imaging tests or laboratory evaluations will be required and patients will be evaluated and treated according to local policy. All the involved centers will be asked to update information on included patients at 2, 4, 6, 8, 10 and 28 days after severe infection diagnosis. Study outcomes: The primary outcome of the study is the development of DIC. Secondary outcomes are thrombotic (arterial and venous) and bleeding events, overall mortality at 28 days. Study sample, feasibility, and analysis plan: We plan to enroll a minimum of 1000 patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Disseminated Intravascular Coagulation

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03577015.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing